Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Navigating Participant Payment Challenges: A New Approach For Sponsors And Sites
As trials grow more sophisticated and operate on a larger, global scale, understanding the nuances of participant payment management has become essential for sponsors and sites alike.
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
PCI Pharma Services Capabilities Update January 2026: Fill/Finish
Patricia highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.
Harnessing AI for Pre-Award Landscape Analysis And Site Selection
AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

What ASCO 2025 Means For The Future Of Oncology Trials
6/13/2025

Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.
CDMO Support: Success In Early-Phase Drug Product Development
4/17/2024

As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering specialized expertise, accelerated timelines, cost efficiency, and risk mitigation.
How Do Site Payments Impact Clinical Trial Sustainability?
4/16/2025

Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,
Successful Regulatory Submission Via The Trifecta Of Awesomeness
1/17/2025

Three essential elements contribute to a repeatable, adaptable regulatory submission process: strategic planning, team engagement, and properly leveraging team experience.
Equitable Access To Clinical Trials & The Trial Modernization Act
11/11/2024

How are the Equitable Access to Clinical Trials (EACT) initiative and Clinical Trial Modernization Act (CTMA) being used to improve clinical trial inclusivity by addressing financial barriers?

SMART First Human Dose (FHD)

A CDMO with the right team of experts can aid drug development, regulatory compliance, and clinical trial supply, accelerating timelines to first human dose clinical trials and the path to market.
An Introductory Guide To Clinical EU Qualified Person (QP) Services

PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.
Pre-Formulation And Material Sciences

Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
Intelligent Trials: Design and Execute Faster Trials with AI-Powered Insights

Explore how Intelligent Trials leverages the industry’s largest clinical dataset to accelerate enrollment, improve diversity, and provide real-time insights, ensuring efficient, data-driven trial success.
Human Abuse Potential

With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.